1168153-63-6

Basic information

• Product Name: 1,4-Piperidinedicarboxylic acid, 4-methyl-3-oxo-, 1-(1,1-dimethylethyl) 4-ethyl ester
• Synonyms: 1,4-Piperidinedicarboxylic acid, 4-methyl-3-oxo-, 1-(1,1-dimethylethyl) 4-ethyl ester
• CAS NO: 1168153-63-6
• Molecular Formula: C14H24NO5
• Molecular Weight: 286.34406
• Mol File: 1168153-63-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 368.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.124±0.06 g/cm3(Predicted)
• PKA: -2.63±0.40(Predicted)
• CAS DataBase Reference: 1,4-Piperidinedicarboxylic acid, 4-methyl-3-oxo-, 1-(1,1-dimethylethyl) 4-ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Piperidinedicarboxylic acid, 4-methyl-3-oxo-, 1-(1,1-dimethylethyl) 4-ethyl ester(1168153-63-6)
• EPA Substance Registry System: 1,4-Piperidinedicarboxylic acid, 4-methyl-3-oxo-, 1-(1,1-dimethylethyl) 4-ethyl ester(1168153-63-6)

Safety Data

• Hazardous Substances Data: 1168153-63-6(Hazardous Substances Data)

Usage

Explanation

Different sources of media describe the Explanation of 1168153-63-6 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. This is the commonly used name for the compound, which is derived from its structural features.
3. The compound is a derivative of piperidinedicarboxylic acid, meaning it is structurally related and has been modified from the parent compound.
4. The compound is used as an important building block in the creation of different pharmaceutical products.
5. The compound's physical form is a white to off-white crystalline powder, which is a common appearance for many organic compounds.
6. The melting point is the temperature range at which the compound transitions from a solid to a liquid state.
7. The compound dissolves in organic solvents, which is a property that can be important for its use in chemical reactions and pharmaceutical applications.
8. The compound is used in the development and production of various medicines and pharmaceuticals due to its properties and reactivity.
9. The compound's properties, such as its solubility and reactivity, make it suitable for use in drug development and research processes.

Derivative

Piperidinedicarboxylic acid

Pharmaceutical Industry Use

Key intermediate in the synthesis of various drugs

Physical Appearance

White to off-white crystalline powder

Melting Point

93-95°C

Solubility

Soluble in organic solvents

Applications

Production of medicines and pharmaceuticals

Suitability for Drug Development and Research

Yes

Upstream product

• 71233-25-5 ethyl 1-tert-butoxycarbonyl-3-oxopiperidine-4-carboxylate 
• 74-88-4 methyl iodide 
• 52763-21-0 ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1310458-59-3 1-(2,4-difluorophenyl)-6-fluoro-7-(4-amino-3-methoxyimino-4-methylpiperidin-1-yl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid 
• 1310458-60-6 1-(2,4-difluorophenyl)-6-fluoro-7-(4-amino-3-ethoxyimino-4-methylpiperidin-1-yl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid 
• 1334412-58-6 N-tert-butoxycarbonyl-3,3-difluoro-4-hydroxymethyl-4-methylpiperidine 
• 1334416-25-9 N-tert-butoxycarbonyl-3,3-fluoro-4-ethoxycarbonyl-4-methylpiperidine 
• 1373503-36-6 N-tert-butoxycarbonyl-3-fluoro-4-ethoxycarbonyl-4-methyl-5,6-dihydropyridine 

Relevant articles and documents

CYCLIC COMPOUNDS AND METHODS OF USING SAME

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof which are MALT1 inhibitors. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for treating diseases, such as cancer, autoimmune disorders, and inflammatory disorders.

Synthesis and in vitro antibacterial activity of 7-(3-Alkoxyimino-4-amino- 4-methylpiperidin-1-yl) fluoroquinolone derivatives

A series of novel 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives were designed, synthesized and evaluated for their in vitro antibacterial activity and cytotoxicity. All of the target compounds have potent antibacterial activ